Abstract:Aim: To investigate the role of voltage-gated K+ (Kv)2.1 channel of pulmonary arterial smooth cells in the attack of hypoxia pulmonary hypertension. Methods: 1 The experiment was carried out in the laborato ry of Department of Thoracic & Cardiovascular Surgery, Renmin Hospital of Wuhan University between April 2003 and June 2006. Forty-eight healthy adult male Wistar rats were randomly divided into 6 groups with 8 rats in each group: control group, hypoxia 3, 7, 14 and 28 days groups. The rats were kept in a normobaric hypoxic chamber. The inspired oxygen fraction was kept at (10±5)%, and the rats, except those in the control group, were made into models of hypoxia pulmonary hypertension for 8 hours and 3, 7, 14 and 28 days. 2 The pulmonary artery pressure wave was recorded, average pulmonary artery pressure was calculated. The concentrations of free K+ and Ca2+ in plasma were detected. The smooth muscle cells (SMCs) nuclear density and media thickness. 3 After staining of pulmonary arterial SMCs, the expressions of surface nuclear antigen and bcl-2 inhibiting apoptosis factor were observed under microscope: 0 as no expression, + as weak expression, ++ as moderate positive, +++ as strong positive. 4 The image biological analysis system was applied to scan the density of point of intersection, and the same treated β-actin mRNA expression amount was taken as the internal reference, and the pulmonary arterial SMCs Kv2.1 mRNA was expressed with the ratio of the two integrated absorbance (A value). 5 The data were treated with analysis of variance, and the t test was applied in the intergroup comparison. Results: All the 48 rats were involved in the an alysis of results. 1 With the elongation of hypoxia time, the average pulmonary artery pressure, SMCs nuclear density and media thickness were gradually increased. The average pulmonary artery pressure was obviously higher in the hypoxia groups than in the control group (P < 0.01), SMCs nuclear density and media thickness were markedly higher in the hypoxia 3, 7, 14 and 28 days groups than in the control group (P < 0.05-0.01). 2 With the elongation of hypoxia time, the free K+ concentration in plasma was gradually decreased, and that of Ca2+ was gradually increased. The free K+ concentration in plasma was obviously lower in the hypoxia 3, 7, 14 and 28 days groups than in the control group (P < 0.05-0.01), and the free Ca2+ concentration in plasma was obviously lower in the hypoxia 7,14 and 28 days groups than in the control group (P < 0.05-0.01). 3 With the elongation of hypoxia time, the positive expression of proliferative cell nuclear antigen and expression of bcl-2 in SMCs were gradually increased and enhanced, those were obviously higher in the 3, 7 and 28 days groups than in the control group (P < 0.05-0.01). 4 With the elongation of hypoxia time, the mRNA expression of Kv2.1 gene in the pulmonary arterial SMCs hypoxia rats tended to be decreased, the ratio with the A value of β-action mRNA were 0.94, 0.90, 0.64, 0.36, 0.26 respectively. Conclusion: 1 The expression of Kv2.1 ge ne was normal in the pulmonary arterial SMCs of normal rats, but decreased in that of hypoxia rats. 2 The decreased activity of Kv2.1 channels also helps to inhibit apoptosis, and increase the cellular proliferation, ultimately lead to vascular reconstruction and development of pulmonary hypertension.

circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA

Role of Oxygen Sensitive Potassium Channels in Pulmonary Arteries Smooth Muscle Cells in Hypoxic Pulmonary Vasoconstriction

Circ-calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation

Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2

Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA‐328‐3p/profilin 1 axis

Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium‐Dependent Hyperpolarization–Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension

Effect of potassium channels on acute hypoxic pulmonary vasoconstriction in COPD and chronic hypoxic patients

A Role for Receptor-Operated Ca2+ Entry in Human Pulmonary Artery Smooth Muscle Cells in Response to Hypoxia.

[Distribution of Ion Channels in Pulmonary Arterial Smooth Muscle Cells and Their Roles in Hypoxia Pulmonary Vasoconstriction].

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.

Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats

CircPMS1 Promotes Proliferation of Pulmonary Artery Smooth Muscle Cells, Pulmonary Microvascular Endothelial Cells, and Pericytes under Hypoxia.

CircNAP1L4 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation Via the NAP1L4-mediated Super- Enhancerdriven Glycolysis Gene Hexokinase II (HK II) in Pulmonary Hypertension

The HIF-1 alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy

Changes of voltage-gated K+2.1 gene expression in pulmonary arterial smooth cells in rats with hypoxic pulmonary hypertension

Inhibition of RhoA/ROCK Signaling Pathway Ameliorates Hypoxic Pulmonary Hypertension Via HIF-1α-dependent Functional TRPC Channels

HIF‐1α Promotes the Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells Via Activation of Cx43

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

Hsa_circwdr37_016 Regulates Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells

Overexpressed lncRNA AC068039.4 contributes to proliferation and cell cycle progression of pulmonary artery smooth muscle cells via sponging miR-26a-5p/TRPC6 in hypoxic pulmonary arterial hypertension

CircNAP1L4 regulates pulmonary artery smooth muscle cell proliferation via the NAP1L4-mediated super-enhancer-driven glycolysis gene hexokinase II (HK II) in pulmonary hypertension